Conclusion
Because little is known about the clinical course and progression of
SARS-CoV-2 infection in newborns after cardiac surgery, the duration of
ECMO support, cannulation and anticoagulation strategy, and the recovery
timetable to guide treatment is unclear. Our case emphasizes the
clinical course of this disease leading to mortality, as well as the
difficulties in managing ARDS and ECMO in the context of SARS-CoV-2
syndrome, especially in newborns who underwent cardiac surgery.